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Abstract
Background:  The clinical, radiological and microbiological features of culture-confirmed childhood
tuberculosis diagnosed at two referral hospitals are described.
Methods: Cultures of Mycobacterium tuberculosis from children less than 13 years of age at Tygerberg and
Red Cross Children's Hospitals, Cape Town, South Africa, were collected from March 2003 through
February 2005. Folder review and chest radiography were performed and drug susceptibility tests done.
Results: Of 596 children (median age 31 months), 330 (55.4%) were males. Of all children, 281 (47.1%)
were HIV-uninfected, 133 (22.3%) HIV-infected and 182 (30.5%) not tested. Contact with infectious
tuberculosis adults was recorded in 295 (49.5%) children. Missed opportunities for chemoprophylaxis
were present in 117/182 (64.3%) children less than 5 years of age.
Extrathoracic TB was less common in HIV-infected than in HIV-uninfected children (49/133 vs. 156/281;
odds ratio 0.50, 95% confidence interval 0.32–0.78). Alveolar opacification (84/126 vs. 128/274; OR 1.85,
95%CI 1.08–3.19) and cavitation (33/126 vs. 44/274; OR 2.28, 95%CI 1.44–3.63) were more common in
HIV-infected than in HIV-uninfected children. Microscopy for acid-fast bacilli on gastric aspirates and
sputum was positive in 29/142 (20.4%) and 40/125 (32.0%) children, respectively. Sixty-seven of 592
(11.3%) children's isolates showed resistance to isoniazid and/or rifampicin; 43 (7.3%) were isoniazid-
monoresistant, 2 (0.3%) rifampicin-monoresistant and 22 (3.7%) multidrug-resistant. Death in 41 children
(6.9%) was more common in HIV-infected children and very young infants.
Conclusion: HIV infection and missed opportunities for chemoprophylaxis were common in children
with culture-confirmed TB. With cavitating disease and sputum or gastric aspirates positive for acid-fast
bacilli, children may be infectious. Transmission of drug-resistant TB is high in this setting.
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Background
In recent years there has been increasing recognition of
the significant contribution of childhood tuberculosis
(TB) to the global burden of TB [1,2]. This increased inter-
national awareness is evidenced by the recent publication
of childhood TB guidance for National TB Programs pub-
lished by the World Health Organization (WHO) and the
access provided to child friendly drug formulations via the
Global Drug Facility (GDF) in 2007 [3]. Children less
than 15 years of age constitute approximately 15% of the
total TB case load in many developing communities [4,5].
Children are mainly infected by adult pulmonary TB
source cases and childhood TB therefore reflects the inten-
sity of ongoing transmission of Mycobacterium tuberculosis
(M. tuberculosis) within a community. The high prevalence
of human immunodeficiency virus (HIV) infection in
many TB-endemic countries fuels the TB epidemic and
complicates the diagnosis of childhood TB.
Although the diagnosis of tuberculosis in the majority of
children who present with symptomatic disease should
not be that difficult, if a constellation of history of contact,
chronic symptoms and special investigations such as
tuberculin skin test (TST) and chest radiography are used
[6], bacteriologic confirmation of the diagnosis is often
lacking. Specimens for culture of M. tuberculosis in chil-
dren, especially infants and young children are difficult to
obtain and are therefore often restricted to hospital set-
tings.
In Cape Town and the surrounding Western Cape Prov-
ince, the majority of specimens positive on culture for M.
tuberculosis in children are collected in two referral hospi-
tals, Tygerberg Children's Hospital (TCH) and Red Cross
Children's Hospital (RCCH). This study describes the
clinical, radiological and microbiological features of all
culture-confirmed childhood TB cases, comparing HIV-
uninfected with HIV-infected children, diagnosed at these
two hospitals over a 2 year period.
Methods
Setting
This prospective study was conducted in the Western Cape
Province of South Africa, which reported a TB incidence of
931 and 1037 per 100 000 population in 2003 and 2005,
respectively [7]. The HIV prevalence among women
attending public antenatal care facilities was 13.1% (95%
CI: 8.5–17.7%) and 15.7% (95% CI: 11.3–20.1%) in
2003 and 2005, respectively [8].
Study population
All cultures of M. tuberculosis from children less than 13
years of age diagnosed at TCH and RCCH, were collected
prospectively from 1 March 2003 through 28 February
2005. Clinical assessment of children for culture of M.
tuberculosis was done by hospital clinicians in a routine
fashion. A folder review and chest radiograph evaluation
was performed on every child.
Drug susceptibility testing
Laboratory procedures were as follows: Middlebrook 7H9
broth based (Mycobacteria Growth Indicator Tubes
[MGIT]; Becton Dickinson, Sparks, MD, USA) culture
medium was used for selective primary isolation of myco-
bacterial strains. M. tuberculosis was identified by polymer-
ase chain reaction (PCR) DNA amplification method [9].
A single M. tuberculosis isolate from each patient was sent
to the National Health Laboratory Service (NHLS) for
drug susceptibility testing (DST). Initial screening was for
isoniazid (INH) and rifampicin (RMP) resistance only; in
case of resistance to either or both drugs, susceptibility
testing for ethambutol was done. For TCH, drug suscepti-
bility testing was by the indirect proportion method on
Löwenstein-Jensen medium containing critical concentra-
tions of 0.2 μg/ml INH, 30 μg/ml RMP and, where indi-
cated, 2 μg/ml ethambutol as previously described [10].
DST for all RCCH isolates was initially performed using
the Bactec 460TB system (Becton Dickinson, Sparks, MD,
USA), according to international criteria [11]. Briefly, the
susceptibility of a strain was judged by comparing growth
of organisms in liquid media containing drug to growth in
medium with no drug. RMP was tested at a concentration
of 2.0 μg/ml, INH at 0.1 μg/ml and ethambutol at 7.5 μg/
ml. Resistance was defined as 1% or more bacterial
growth. DST by the indirect proportion method on Löw-
enstein-Jensen medium was repeated on all drug-resistant
isolates and 20% of the drug-susceptible strains from
RCCH. Quality assurance for drug susceptibility results
was done locally with every batch and quarterly by the
national tuberculosis reference laboratory as described
previously [11,12].
Clinical data and treatment
The clinical records of all children with a positive M. tuber-
culosis culture were reviewed. Data retrieved were demo-
graphic information, a history of close contact with an
adult with smear or culture-positive pulmonary TB, a his-
tory of previous TB chemoprophylaxis or treatment, clini-
cal features and weight at presentation, Mantoux
(tuberculin skin test or TST) results, HIV status and
whether antiretroviral therapy was started, TB disease
manifestations recorded and hospital outcome.
Previous TB treatment was defined as more than 1 month
of any antituberculosis treatment. Weight at admission
was used to classify children as being well-nourished or
having severe malnutrition (marasmus and/or kwash-
iorkor) according to the Wellcome classification [13]. The
TST was considered positive with an induration of ≥ 10
mm in HIV-uninfected and ≥ 5 mm in HIV-infected chil-BMC Infectious Diseases 2007, 7:140 http://www.biomedcentral.com/1471-2334/7/140
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dren. HIV tests were requested at the discretion of the
attending doctor. HIV infection was confirmed by two
enzyme-linked immunosorbent assays (ELISA) in chil-
dren ≥ 18 months old and by PCR in children younger
than 18 months of age. All chest radiographs were read by
a single paediatric TB specialist in a standardized manner
[14].
Children with drug-susceptible TB were treated according
to the directly observed treatment, short-course (DOTS)
policy of the South African National Tuberculosis Pro-
gramme (NTP), using INH, RMP and pyrazinamide (PZA)
for 6 months [15]. Children with drug-resistant TB
received individualized treatment according to their spe-
cific drug susceptibility pattern [16].
Categorical data were analyzed using the Chi-square test.
The Fisher's exact test was applied where appropriate. Sta-
tistical analysis was done using Epi-Info version 6.04. The
study was approved by the Ethics Review Board, Health
Sciences Faculty, Stellenbosch University and permission
for the study was obtained from both hospitals.
Results
Of the 596 children (55.4% males) with culture-con-
firmed tuberculosis, 323 were from TCH and 277 from
RCCH (4 children had a positive culture during the same
TB episode at both hospitals). The median age was 31
months (range 16 days-156 months). Thirty three (5.5%)
were infants less than 3 months of age, 156 (26.2%) were
less than 1 year and 425 (71.3%) children were less than
5 years of age at diagnosis. Previous treatment and contact
history, clinical data and special investigations are sum-
marized in Table 1.
HIV status
HIV status was evaluated in 414 (69.5%) children. Of all
children, 281 (47.1%) were confirmed HIV-uninfected,
133 (22.3%) were HIV-infected and in 182 (30.5%) the
status was not known (in 2 cases mothers were known to
be HIV-infected). Only 14 of the 133 (10.5%) HIV-
infected children were on antiretroviral therapy at the
time of TB diagnosis.
History of TB contact and previous treatment
A history of contact with an infectious pulmonary TB case
was recorded in 295 (49.5%) children. The source case
was a parent in 121 (41.0%), an uncle/aunt in 68
(23.1%), a grandparent in 26 (8.8%), an older sibling in
15 (5.1%), other household cases in 27 (9.2%), a neigh-
bour in 19 (6.4%) and another or unknown case in 28
(9.5%). Twenty three children (7.8%) had more than one
source case. Two children, whose case histories have pre-
viously been published, were infected in a kangaroo care
unit by a parent of another child [17] and one child was
most likely infected by patients visiting their house for
Table 1: History, clinical characteristics and drug susceptibility test results in children with culture-confirmed TB according to HIV 
status (n = 596)
Characteristic HIV-uninfected N = 281 (%) HIV-infected N = 133 (%) HIV unknown N = 182 (%) Odds ratio (95% CI)a
Previous TB treatment 26 (9.3) 40 (30.1) 16 (8.8) 0.24 (0.13–0.42)
Known TB source case 152 (54.1) 73 (54.9) 70 (38.5) NS
Nutritional status (n = 276) (n = 128) (n = 173)b
Severely malnourished 53 (19.2) 26 (20.3) 20 (11.6) NS
< 3rd percentile WFA 78 (27.8) 57 (42.9) 44 (24.2) 0.49 (0.31–0.78)
Total malnourished 131 (46.6) 83 (62.4) 64 (35.2) 0.49 (0.31–0.77)
TST (Mantoux) positive 190/232 (81.9) 50/83c (60.2) 90/110 (81.8) 2.99 (1.66–5.38)
DST results (n = 277)d
All drug resistance 31 (11.2) 23 (17.3) 13 (7.1) NS
INH monoresistance 21 (7.5) 12 (9.0) 10 (5.5) NS
RMP monoresistance 0 2 (1.5) 0
MDR 10 (3.6) 9 (6.8) 3 (1.6) NS
TB manifestation:
Intrathoracic TB onlye 126 (44.8) 84 (63.2) 96 (52.7) 0.47 (0.30–0.74)
Intra- and extrathoracic TBe 119 (42.3) 44 (33.1) 48 (26.4) NS
Extrathoracic TB only 37 (13.2) 5 (3.8) 37 (20.3) 3.07 (1.41–11.48)
All extrathoracic TB 156 (55.5) 49 (36.8) 85 (46.7) 2.12 (1.36–3.32)
CI = confidence interval; WFA = weight for age; TST = tuberculin skin test; DST = drug susceptibility test; INH = isoniazid; RMP = rifampicin; MDR 
= multidrug-resistant
a: comparison between HIV-uninfected and HIV-infected groups
b: significantly fewer children were malnourished among those not HIV tested compared to those tested for HIV (OR 1.91; 1.30–2.80)
c: only 2 with TST 5–9 mm induration
d: in 4 HIV-uninfected children DST was not done
e: intrathoracic TB includes pleural and pericardial effusions
NS = not significantBMC Infectious Diseases 2007, 7:140 http://www.biomedcentral.com/1471-2334/7/140
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directly observed treatment (DOT), the mother being a
DOT supporter. Missed opportunities for chemoprophy-
laxis, defined as no previous antituberculosis treatment
and a known household source case in children less than
5 years of age, were present in 117 of 182 (64.3%) chil-
dren.
Eighty two children (13.8%) had received previous TB
treatment; 13 had received chemoprophylaxis, 11 were
currently on treatment for > 1 month and 58 had received
a previous course of treatment.
Disease manifestations by HIV status
Extrathoracic TB was common in all groups. Table 2
reflects the extrathoracic TB manifestations recorded,
according to the HIV status of the child. Significantly less
extrathoracic TB was seen in HIV-infected children com-
pared to HIV-uninfected (OR 0.50, 95% CI 0.32–0.78).
Specific differences in subtype of extrathoracic TB
observed more commonly in HIV-uninfected than HIV-
infected children were in TB meningitis (68/281 vs. 10/
133; OR 3.93, 95% CI 1.87–8.44) and osteoarticular TB
(1/281 vs. 5/133; p = 0.014). Congenital TB occurred in 6
(1.0%) infants; 3 in HIV-uninfected, 1 HIV-infected and 2
with unknown HIV status.
Presenting symptoms were not always available in the
records. Cough > 2 weeks was noted in 344 (57.7%) (337/
517; 65.2% of those with intrathoracic disease), weight
loss or failure to gain weight in 318 (53.4%) and fever in
284 (47.7%). Other symptoms noted were associated
mainly with extrathoracic TB; neck mass (78; 13.1%), loss
of consciousness (34; 5.7%), convulsions (27; 4.5%) and
abdominal distension (26; 4.4%).
Table 3 demonstrates the intrathoracic TB manifestations
seen on chest radiography (n = 555) according to the HIV
status of the child. A significantly higher proportion of
alveolar opacification (OR 1.85, 95%CI 1.08–3.19) and
cavitation (OR 2.28, 95%CI 1.44–3.63) was recorded in
HIV-infected compared to HIV-uninfected children and
fewer HIV-infected children had normal chest radio-
graphs (OR 0.31, 95%CI 0.10–0.87). There was no signif-
icant difference in the occurrence of cavitation by age
group (0–2 years vs. > 2 years; 0–5 years vs. > 5 years or
0–9 years vs. > 9 years of age). Cavitation in younger chil-
dren was mainly breakdown in a consolidated segment or
lobe, while older children had more adult-type TB.
Culture source and microscopy results
Of 935 culture-positive isolates, 740 (79.1%) were pul-
monary specimens (440 gastric aspirates, 202 sputum, 57
tracheal/bronchial aspirates and 41 nasopharyngeal aspi-
rates). Lung or mediastinal lymph node biopsy yielded an
additional 10 positive cultures. Of 185 (19.8%) culture-
positive extrapulmonary specimens, 74 were from periph-
eral lymph nodes, 46 from cerebrospinal fluid, 13 from
pleural and 4 from pericardial fluid, 15 from bone/sino-
vial tissue, 6 from ascites/abdominal tissue, 10 from mas-
toid or ear swabs, 3 from parotid aspirates, 1 from eye
tissue and 13 from abscess pus swabs.
Staining and microscopy for acid-fast bacilli (AFB) on res-
piratory secretions (sputum, induced sputum, gastric aspi-
rates and nasopharyngeal aspirates) was done in 309
children. AFB on gastric aspirates was positive in 29 of 142
(20.4%) children. AFB yield on self-expectorated sputum
was 34 of 92 (37.0%) and 40 of 125 (32.0%) if induced
sputum was included.
Table 2: Extrathoracic disease manifestations based on HIV status in children with culture-confirmed tuberculosis
Extrathoracic disease 
manifestation
All children N = 596 (%) HIV-uninfected N = 281 (%) HIV-infected N = 133 (%) HIV unknown N = 182 (%)
Miliary TB 69 (11.6) 44 (15.7) 19 a (14.3) 6 (3.3)
TB meningitis e 89 (14.9) 68 (24.2) 10 (7.5) 11 (6.0)
Miliary TB & TB meningitis b 25 (4.2) 18 (6.4) 6 (4.5) 1 (0.5)
Abdominal TB 43 (7.2) 24 (8.5) 14 (10.5) 5 (2.7)
Lymph node TB c 94 (15.8) 40 (14.2) 13 (9.8) 41 (22.5)
Osteoarticular TB d, f 18 (3.0) 1 (0.2) 5 (3.8) 12 (6.6)
Mastoid & ear TB 9 (1.5) 2 (0.7) 3 (2.3) 4 (2.2)
Mastoiditis 7 2 1 4
Chronic otorrhoea 2 0 2 0
Parotid gland 3 (0.5) 0 0 3 (1.6)
Renal TB 1 (0.2) 0 1 (0.8) 0
Skin involvement 8 (1.3) 3 (1.1) 0 5 (2.7)
a: Lymphoid interstitial pneumonitis excluded by treatment response
b: Included in miliary TB and TB meningitis above
c: All histologic or culture confirmed. A further 10 children had suspected TB lymph nodes
d: Orthopaedic patients: Spinal TB (6), hip TB (5), skull lesion (3), knee TB (2)
e: HIV-uninfected vs. HIV-infected group: odds ratio 3.93 (95% confidence interval 1.87–8.44)
f: HIV-uninfected vs. HIV-infected group: p = 0.014BMC Infectious Diseases 2007, 7:140 http://www.biomedcentral.com/1471-2334/7/140
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Drug susceptibility test results
Drug susceptibility testing was done on isolates of 592
(99.3%) children. In 4 cases isolates were lost or contam-
inated. The results of the DST from TCH were previously
published [18]. Of the 592 isolates, 67 (11.3%) showed
resistance to INH and/or RMP; 43 (7.3%) were INH-
monoresistant, 2 (0.3%) were RMP-monoresistant and 22
(3.7%) were MDR. Three INH-monoresistant isolates
from RCCH by the Bactec DST method showed no resist-
ance by the Löwenstein-Jensen DST method, while all
retested drug-susceptible isolates showed the same result
as with Bactec DST method. For consistency of results, the
Löwenstein-Jensen DST results were accepted. The overall
number of resistant cases did not differ significantly
between the two hospitals (39/315, 12.4% from TCH vs.
28/277, 10.1% from RCCH; odds ratio 0.80, 95% confi-
dence interval 0.46–1.37). There was no significant differ-
ence in the proportion of HIV-uninfected and infected
cases with drug resistance.
Drug-resistance was significantly more in previously
treated children (20/82; 24.4%) compared to children
with no or unknown previous TB treatment (47/514;
9.1%. OR 0.31, 95% CI 0.17–0.59). DST results were
known from only 18 source cases; 6 had MDR TB (5 chil-
dren with MDR TB), 1 was RMP mono-resistant, as was
the child, and 11 had drug-susceptible TB (10 children
with drug-susceptible TB, 1 with MDR TB).
Management and outcome
Treatment initiation was documented in 570 (95.6%)
children; 380 (63.8%) were referred to their local health
clinic for treatment, 98 (16.4%) were admitted to TB hos-
pitals, 34 (5.7%) were transferred back to the hospital
from where they were referred, 8 (1.3%) remained in the
same hospital, in 9 (1.5%) cases the place of transfer was
not noted and 41 (6.9%) children died. Of those admitted
to TB hospitals for treatment, 81 (82.7%) had severe
extrapulmonary TB; TB meningitis in 54, miliary TB in 10,
abdominal TB in 18, pericardial effusion in 4 and spinal
TB in 2 (some > 1 type). Thirteen of 98 (13.26%) admis-
sions were drug-resistant cases (10 MDR) and 24 (24.5%)
were HIV-infected. In total 41 died; 18/281 (6.4%) HIV-
uninfected, 17/133 (12.8%) HIV-infected, and 6/182
(3.3%) in whom the HIV status was unknown. Signifi-
cantly more HIV-infected children died compared to the
other groups (OR 2.14, 95% CI 1.01–4.54 and 4.30,
1.54–12.61, respectively). Further, 9/67 (13.4%) (6 INH-
monoresistant, 2 also HIV-infected, and 3 MDR, all 3 HIV-
infected) children with drug-resistant TB died compared
to 32/525 (6.1%) with known drug-susceptible TB (OR
2.39, 95% CI 1.00–5.55). Death was also significantly
related to young age (Table 4) and 8 of 33 (24.2%) infants
Table 3: Intrathoracic disease manifestations on chest radiograph based on HIV status in children with culture-confirmed tuberculosis
Intrathoracic disease 
manifestationb
All childrena n = 555 (%) HIV-uninfected n = 274 (%) HIV-infected n = 126 (%) HIV unknown n = 155 (%)
Lymphadenopathy (all) 288 (51.9) 142 (51.8) 71 (56.3) 75 (48.4)
Paratracheal only 18 (3.2) 9 5 4
Perihilar only 192 (34.6) 91 46 55
Both 78 (14.1) 42 20 16
Large airway compression 97 (17.5) 54 (19.7) 17 (13.5) 26 (16.8)
Perihilar opacification 38 (6.8) 15 (5.5) 8 (6.3) 15 (9.7)
Alveolar opacification lobe/
segment e
285 (51.4) 128 (46.7) 84 (66.7) 73 (47.1)
Bronchopneumonic opacification 55 (9.9) 28 (10.2) 12 (9.5) 15 (9.7)
Collapse lobe/segment 52 (9.4) 23 (8.4) 14 (11.1) 15 (9.7)
All cavities/breakdownf 106 (19.1) 44 (16.1) 33 (26.2) 29 (18.7)
Pleural effusion (all) 83 (15.0) 37 (13.5) 17 (13.5) 29 (18.7)
Large effusions 29 (5.2) 9 (3.3) 5 (4.0) 15 (9.7)c
Pericardial effusion 11 (2.0) 6 (2.1) 3 (2.3) 2 (1.1)
Miliary picture 69 (12.4) 44 (16.1) 19 (15.1) d 6 (3.9)
Ghon focus 26 (4.7) 18 (6.6) 3 (2.4) 5 (3.2)
Hyperinflation 15 (2.7) 6 (2.2) 5 (4.0) 4 (2.6)
Calcification 13 (2.3) 4 (1.5) 4 (3.2) 5 (3.2)
Normal chest radiographg 53 (9.5) 32 (11.7) 5 (4.0) 16 (10.3)
a: 41 chest radiographs not done (extrapulmonary TB) or lost
b: In case of uncertainty about a characteristic, it is reported as not present
c: Older children had more large effusions and were less often HIV tested.
d: A further 8 patients had lymphoid interstitial pneumonitis
e: HIV-uninfected vs. HIV-infected group: odds ratio 0.44 (95% confidence interval 0.28–0.70)
f: HIV-uninfected vs. HIV-infected group: OR 0.54 (95% CI 0.31–0.93)
g: HIV-uninfected vs. HIV-infected group: OR 3.20 (95% CI 1.15–9.60)BMC Infectious Diseases 2007, 7:140 http://www.biomedcentral.com/1471-2334/7/140
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less than 3 months died compared to 33/563 (5.9%) chil-
dren more than 3 months of age (OR 5.35, 95% CI
2.03–13.75). Of those less than 3 months of age that died,
4 had congenital TB, 3 had miliary and 1 bilateral bron-
chopneumonic TB, 2 were HIV-infected and 2 had INH-
resistant TB. Death occurred within the first 2 weeks after
admission in 18/41 (43.9%) and within 3 months follow-
ing admission in 32/41 (78.0%).
Discussion
To our knowledge this is the largest cohort of culture-con-
firmed childhood TB described in the literature. It must be
emphasized that this hospital-based study probably repre-
sents a biased population of sicker children, but we
believe it should provide a good overview of children with
definite (culture confirmed) TB who present to referral
hospitals in TB-endemic settings.
Young and/or HIV-infected children carried the brunt of
the TB disease burden; the age distribution (> 70% of chil-
dren less than 5 years of age) reflects a high rate of recent
M. tuberculosis transmission in this setting. Current NTP
and WHO guidelines for the management of children in
close contact with an infectious adult source case recom-
mend chemoprophylaxis for children less than 5 years of
age [3,15]. In this study, missed opportunities for chemo-
prophylaxis were present in the majority, and represented
a key opportunity for intensified TB control in children. A
source case was identified more often in young children
(< 3 years of age) and a parent was the source case in many
of these children.
From the few children in whom the DST results of the
source cases were known, it is clear that the DST results of
a probable adult source case are highly relevant and
should guide the initial management of child contacts
[3,16]. However, due to resource constraints culture and
DST are rarely performed in TB-endemic areas, which fre-
quently delays initiation of the correct treatment in child-
hood contacts or prevents even their identification.
Current (2006) WHO childhood TB guidelines recom-
mend that all children suspected of having TB in a high
HIV prevalence area or at high risk of HIV infection
should be tested for HIV, as this may guide clinical man-
agement [3]. Although about 70% of children in the study
Table 4: Clinical and laboratory features of children with culture-confirmed TB, compared in relevant age groups
Feature Age < 3 years n = 334 (%) Age > 3 years n = 262 (%) Odds ratio (95% CI)
History of TB contact 183 (54.8) 112 (42.7) 1.62 (1.16–2.20)
Parent with TB 83 (24.9) 38 (14.5) 1.95 (1.25–3.05)
Previous TB treatment 33 (9.9) 49 (18.7) 0.48 (0.29–0.79)
Malnutrition/WFA < 3rd centile 170/320 (53.1) 107/258 (41.5) 1.60 (1.13–2.26)
Tuberculin skin test ≥ 10 mm 176/238 (73.9) 151/187 (80.7) NS
All pulmonary TB 303 (90.7) 214 (81.7) 2.19 (1.32–3.66)
All extrapulmonary TB 144 (43.1) 164 (62.6) 0.45 (0.32–0.64)
Miliary [also TB meningitis] 43 (12.9) [12 (3.6)] 26 (9.9) [13 (5.0)] NS
TB meningitis 49 (14.7) 40 (15.3) NS
Pleural effusion (large) 4 (1.2) 25 (9.5) 0.11 (0.03–0.35)
Lymph node TB 42 (12.6) 52 (19.8) 0.58 (0.36–0.93)
Abdominal TB 15 (4.5) 28 (10.7) 0.39 (0.20–0.78)
Osteoarticular TB 3 (0.9) 15 (5.7) 0.15 (0.03–0.56)
Other EPTB 10 (3.0) 23 (8.8) 0.32 (0.14–0.72)
HIV test done 258 (77.2) 156 (59.5) 2.31 (1.59–3.34)
HIV-infected (of those done) 77 (29.8) 56 (35.9) NS
Outcome – Died 31 (9.3) 10 (3.8) 2.58 (1.19–5.74)
Chest radiographic features n = 299 n = 256 0.20 (0.07–0.51)
Lymphadenopathy 175 (58.5) 113 (44.1) 1.79 (1.26–2.54)
Airway compression 86 (28.8) 11 (4.3) 8.99 (4.52–18.33)
Alveolar opacification 179 (59.9) 106 (41.4) 2.11 (1.48–3.01)
Expansile pneumonia 25 (8.4) 9 (3.5) 2.50 (1.09–5.90)
Bronchopneumonic opac 33 (11.0) 22 (8.6) NS
Collapse lobe/segment 31 (10.4) 21 (8.2) NS
Cavities 55 (18.4) 51 (19.9) NS
Ghon focus 17 (5.7) 9 (3.5) NS
Hyperinflation 17 (5.7) 0 P < 0.001
Calcification 1 (0.3) 12 (4.7) P = 0.002
Normal chest radiograph 26 (8.7) 28 (10.9) NS
WFA = weight for age; NS = not significantBMC Infectious Diseases 2007, 7:140 http://www.biomedcentral.com/1471-2334/7/140
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were tested for HIV, many children in this high HIV prev-
alence area were not tested, even in some cases where their
mothers were known to be HIV-infected. Knowing the
HIV status is important, because several other HIV related
conditions may mimic TB in HIV-infected children, which
makes the diagnosis of TB more complex. HIV infection
was confirmed in 32.1% of those tested, indicating the
high risk of TB in HIV-infected children. This probably
represents an overestimation of HIV prevalence among
childhood TB patients in general, due to the patient selec-
tion alluded to earlier and the fact that children with
symptoms or signs suspicious of HIV infection would
have been more likely to have been tested. Even though
the recorded HIV prevalence is very high, it is far lower
than that recorded in adult TB patients from the same
area. It illustrates, however, the need for integrated TB/
HIV diagnosis and care in children.
Despite TST results being significantly more often positive
in HIV-uninfected children compared to HIV-infected
children (Table 1), the latter group had a remarkably high
proportion (60.2%) of positive TST results, which con-
firms its value as a diagnostic tool even in HIV-infected
children.
Lung cavities were not uncommon (19.1%) and were sig-
nificantly more common in HIV-infected than HIV-unin-
fected children, which confirms findings in earlier studies
in children [19,20]. Other underlying lung conditions
such as bronchiectasis or previous staphylococcal infec-
tions could partly be responsible for cavities being more
common in HIV-infected children. Cavities are associated
with a high mycobacterial load and therefore these chil-
dren pose a transmission risk [21].
Miliary TB was more common in HIV-uninfected com-
pared to HIV-infected children, which differs from previ-
ous reports [19,20]. Extrathoracic TB, especially TB
meningitis, was less common in HIV-infected children
compared to HIV-uninfected children, which could reflect
a reduction in immune mediated pathology in these chil-
dren or perhaps that HIV infection precedes childhood TB
infection (unlike adults, where TB infection often pre-
cedes HIV infection and dissemination of organisms may
already have occurred by the time they are infected with
HIV) and the rapidity of disease onset does not give time
for dissemination and development of disease at sites
other than the lungs. The finding is consistent with previ-
ous reports and also with the observation that HIV-
infected children are less likely to develop the pathogno-
monic basal enhancement seen in immune competent
children with TB meningitis [22,23].
This is also the largest cohort of children in whom DST
has been done and is an accurate reflection of current
transmission patterns. Drug resistance was common with
11.3% resistance to INH and/or RMP. This is significantly
higher than a previous survey done at TCH from
1994–1998 (all resistance 21/306; 6.9%. OR 0.58, 95%
CI 0.34–0.99) [10]. Despite the significantly higher
number of HIV-infected children who had received previ-
ous TB treatment, there was no significant increase in drug
resistance in HIV-infected children compared to HIV-
uninfected children. However, previously treated children
had significantly more drug-resistant TB than children
with new TB, but as shown in our previous report on drug
surveillance from TCH during the same period, the major-
ity of these children had transmitted drug resistance,
which was initially missed [18].
The study confirms the wide spectrum of TB disease man-
ifestations seen in children who present to a referral hos-
pital. TB was cultured from nearly every organ; however
renal disease was the rarest manifestation. TB meningitis
and miliary TB was common before and after 3 years of
age, which could reflect referral bias or the fact that speci-
mens for culture are more easily obtained in older chil-
dren. Large TB pleural effusions were rarely seen before
age 3 years and other forms of extrathoracic TB were also
significantly more common in children > 3 years of age
(Table 4). This is consistent with the literature. Several
chest radiographic features were significantly more com-
mon in children < 3 years of age (Table 4), especially
nodal airway compression. Fifty-one of 97 (52.6%) chil-
dren with airway compression were less than 12 months
of age.
Death as a hospital outcome measure was significantly
more common in HIV-infected children and those with
drug-resistant TB, although 5 of 9 drug-resistant cases who
died were also HIV-infected. Only a minority of HIV-
infected children received antiretroviral therapy at the
time. Improved access to antiretroviral therapy should
decrease the incidence of disease and improve the out-
come of TB in HIV-infected children.
Conclusion
Missed opportunities for chemoprophylaxis in children
less than 5 years of age were common in this study group.
The occurrence of HIV infection was high (32.1% of those
tested) in children with culture-confirmed TB. Extratho-
racic TB was less common in HIV-infected children with
confirmed TB compared to HIV-uninfected children. With
cavitating disease and sputum or gastric aspirates positive
for acid-fast bacilli, children may be infectious. The prev-
alence of INH and/or RMP resistance in the study reflects
a high rate of transmission of drug-resistant TB in this set-
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